HDM2 inhibition augments the antitumor and antiangiogenic effects of sunitinib by suppressing sunitinib-induced SDF-1 expression and tumor recruitment of CD11b/Gr1+MDSC in RCC xenografts
单位：[1]Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA[2]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[3]Brigham & Womens Hosp, Boston, MA 02115 USA
第一作者单位：[1]Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
推荐引用方式(GB/T 7714)：
Panka David J.,Liu Qinjun,Signoretti Sabina,et al.HDM2 inhibition augments the antitumor and antiangiogenic effects of sunitinib by suppressing sunitinib-induced SDF-1 expression and tumor recruitment of CD11b/Gr1+MDSC in RCC xenografts[J].CANCER RESEARCH.2012,72:doi:10.1158/1538-7445.AM2012-1021.
APA：
Panka, David J.,Liu, Qinjun,Signoretti, Sabina&Mier, James W..(2012).HDM2 inhibition augments the antitumor and antiangiogenic effects of sunitinib by suppressing sunitinib-induced SDF-1 expression and tumor recruitment of CD11b/Gr1+MDSC in RCC xenografts.CANCER RESEARCH,72,
MLA：
Panka, David J.,et al."HDM2 inhibition augments the antitumor and antiangiogenic effects of sunitinib by suppressing sunitinib-induced SDF-1 expression and tumor recruitment of CD11b/Gr1+MDSC in RCC xenografts".CANCER RESEARCH 72.(2012)
医学